Q1 2025 Adaptimmune Therapeutics PLC Earnings Call Transcript

Author's Avatar
May 13, 2025

May 13, 2025 / 12:00PM GMT
Operator

Hello and welcome to Adaptimmune's first-quarter 2025 business update conference call. (Operator Instructions) the conference is being recorded. (Operator Instructions).

I will now turn the call over to Julie Miller of Investor Relations for Adaptimmune. Julie, please go ahead.

Julie Miller - Adaptimmune Therapeutics PLC - Vice President of Corporate Affairs and Investor Relations

Thank you. Good morning, and welcome to Adaptimmune's conference call to discuss our first-quarter 2025 business update. I would ask you to review the full text of our forward-looking statements from this morning's press release. We anticipate making projections during this call, and actual results could differ materially due to several factors, including those outlined in our latest filings with the SEC.

Adrian Rawcliffe, our Chief Executive Officer, is here with me for the prepared portion of the call, and other members of our leadership team will be available for Q&A. With that, I'll turn the call over to Adrian Rawcliffe. Ad?

Adrian Rawcliffe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot